What Researchers Did
Researchers conducted a randomized controlled trial with 104 patients with sudden sensorineural hearing loss to compare alprostadil alone versus alprostadil combined with hyperbaric oxygen.
What They Found
Patients receiving alprostadil combined with hyperbaric oxygen (Group B, n=52) showed significantly higher overall recovery rates for tinnitus, aural fullness, and vertigo compared to those receiving alprostadil alone (Group A, n=52) (P<0.05). This combination also led to significantly lower whole blood viscosity compared to alprostadil alone (P<0.05), suggesting improved hemorheology and promoting hearing recovery.
What This Means for Canadian Patients
Canadian patients with sudden sensorineural hearing loss might benefit from a combination therapy of alprostadil and hyperbaric oxygen to improve hearing recovery and reduce associated symptoms. This approach could offer a more effective treatment option for a condition that currently lacks specific regimens.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The abstract does not explicitly detail the study's limitations.